Synlab AG
XETRA:SYAB
Synlab AG
Income from Continuing Operations
Synlab AG
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Synlab AG
XETRA:SYAB
|
Income from Continuing Operations
€93m
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Income from Continuing Operations
€716.9m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-2%
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Income from Continuing Operations
€527m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-11%
|
|
Vita 34 AG
XETRA:V3V
|
Income from Continuing Operations
-€2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Income from Continuing Operations
HK$133.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Synlab AG's Income from Continuing Operations?
Income from Continuing Operations
93m
EUR
Based on the financial report for Dec 31, 2023, Synlab AG's Income from Continuing Operations amounts to 93m EUR.
What is Synlab AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
35%
Over the last year, the Income from Continuing Operations growth was -39%. The average annual Income from Continuing Operations growth rates for Synlab AG have been 35% over the past three years .